These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4345587)

  • 41. [Production, purification and characterization of some Clostridium perfringens toxins].
    Capunzo M; Mariano A; Cavallo R
    G Batteriol Virol Immunol; 1982; 75(1-6):48-61. PubMed ID: 6315516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultrastructural studies on the lesion produced in skeletal muscle fibers by crude type A Clostridium perfringens toxin and its purified alpha fraction.
    Strunk SW; Smith CW; Blumberg JM
    Am J Pathol; 1967 Jan; 50(1):89-107. PubMed ID: 4289263
    [No Abstract]   [Full Text] [Related]  

  • 43. [Preliminary data on the purification and structure of Clostridium perfringens alpha-toxin].
    Teodorescu G; Bittner J; Ceacăreanu A
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):541-4. PubMed ID: 4328576
    [No Abstract]   [Full Text] [Related]  

  • 44. [Microcirculatory changes following the combined action of the toxin of C1. perfringens type A and biological products of C1. butyricum].
    Tselukh AV; Donskikh EA; Shtefan EE; Shtykhno IuM
    Biull Eksp Biol Med; 1977 Nov; 84(11):552-4. PubMed ID: 201314
    [No Abstract]   [Full Text] [Related]  

  • 45. Morphologic and biochemical effects of Clostridium perfringens alpha toxin on intact and isolated skeletal muscle mitochondria.
    Grossman IW; Heitkamp DH; Sacktor B
    Am J Pathol; 1967 Jan; 50(1):77-88. PubMed ID: 4289262
    [No Abstract]   [Full Text] [Related]  

  • 46. [Apropos of the action mechanism of staphylotoxin].
    Masek K; Raskova H
    J Physiol (Paris); 1967; 59(4 Suppl):456. PubMed ID: 4306150
    [No Abstract]   [Full Text] [Related]  

  • 47. [Microcirculation changes in acute occlusion of mesenteric vessels according to vital microscopy data].
    Banin VV
    Arkh Anat Gistol Embriol; 1972 Jan; 62(1):54-61. PubMed ID: 5017892
    [No Abstract]   [Full Text] [Related]  

  • 48. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
    Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The toxins of Clostridium perfringens type C].
    Nedialkov S; Peichev B
    Vet Med Nauki; 1974; 11(2):73-8. PubMed ID: 4370604
    [No Abstract]   [Full Text] [Related]  

  • 50. [Conditions of formation of anatoxins of Clostridium perfringens, Cl. Oedematiens and Cl. septicum from toxins obtained in casein media].
    Nechaevskaia MR; Cherkas GP; Kalinichenko NF; Berezhkovskaia LIa; Biriukova SV; Podgornaia LG; Mukhina AA; Polchenko OT; Leĭbova IM; Konik VIa
    Mikrobiol Zh; 1966; 28(4):56-61. PubMed ID: 4297878
    [No Abstract]   [Full Text] [Related]  

  • 51. A study of the competition of lecithin and antitoxin for Cl.welchii alpha toxin (lecithinase) using a new manometric technique.
    ZAMECNIK PA; LIPMANN F
    Fed Proc; 1946; 5(1 Pt 2):256. PubMed ID: 21064617
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of Clostridium perfringens phospholipase C(alpha-toxin) on the human diploid fibroblast membrane.
    Möllby R; Thelestam M; Wadström T
    J Membr Biol; 1974; 16(4):313-30. PubMed ID: 4366075
    [No Abstract]   [Full Text] [Related]  

  • 53. Fusion of chicken erythrocytes by phospholipase C (Clostridium perfringens). The requirement for hemolytic and hydrolytic factors for fusion.
    Sabban E; Loyter A
    Biochim Biophys Acta; 1974 Aug; 362(1):100-9. PubMed ID: 4371392
    [No Abstract]   [Full Text] [Related]  

  • 54. Vascular permeability changes in inflammation. II. The effect of lecithinase antagonists in ultraviolet injury in the guinea-pig.
    Logan G; Wilhelm DL
    Br J Exp Pathol; 1966 Aug; 47(4):324-30. PubMed ID: 4958347
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of leu-enkephalin and tyrosine on lymphatic and blood microvessels].
    Khugaeva VK; Suchkov VV; Titov MI
    Kardiologiia; 1982; 22(6):83-6. PubMed ID: 7120745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies on the production of anaerobic toxins. 2. Type A Clostridium perfringens toxin].
    Vitèz I; Maróczi J
    Acta Pharm Hung; 1968 Nov; 38(6):405-10. PubMed ID: 4303232
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of lecithinase C of Cl. perfringens type A on blood, bone marrow and phagocytic activity of the leukocytes of guinea pigs immunized with analecithinase].
    Anosov IIa; Larina IA; Ispolatovskaia MV
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Oct; 48(10):65-9. PubMed ID: 4330845
    [No Abstract]   [Full Text] [Related]  

  • 58. Carbon labeling of injured microvessels--relation to vascular permeability and microvascular patency.
    Wells FR
    Bibl Anat; 1973; 12():146-51. PubMed ID: 4790344
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunopurification of phospholipase C (alpha-toxin) from Clostridium perfringens.
    Bird RA; Low MG; Stephen J
    FEBS Lett; 1974 Aug; 44(3):279-81. PubMed ID: 4370089
    [No Abstract]   [Full Text] [Related]  

  • 60. The lecithinase of Clostridium bifermentans and its relation to the alpha-toxin of Clostridium welchii.
    MILES EM; MILES AA
    J Gen Microbiol; 1947 Sep; 1(3):385-99. PubMed ID: 20270639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.